These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 10933576)

  • 1. Effects of acute and chronic angiotensin receptor blockade on myocardial vascular blood volume and perfusion in a pig model of coronary microembolization.
    Schmermund A; Lerman LO; Rumberger JA; Lund PE; Pfeifer EA; Sheedy PF; Ritman EL
    Am J Hypertens; 2000 Jul; 13(7):827-37. PubMed ID: 10933576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of the angiotensin II AT1 receptor antagonist irbesartan on ischemia/reperfusion injury in the dog heart.
    Preckel B; Schlack W; Gonzàlez M; Obal D; Barthel H; Thämer V
    Basic Res Cardiol; 2000 Oct; 95(5):404-12. PubMed ID: 11099168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiotensin II subtype-1 receptor blockade during the development of left ventricular hypertrophy in dogs: effects on ventricular and myocyte function.
    Spinale FG; Holzgrefe HH; Walker JD; Mukherjee R; Kribbs SB; Powell JR; Antonaccio M
    J Cardiovasc Pharmacol; 1997 Nov; 30(5):623-31. PubMed ID: 9388045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of angiotensin II AT1-receptor blockade on coronary dynamics, function, and structure in postischemic heart failure in rats.
    Gervais M; Fornes P; Richer C; Nisato D; Giudicelli JF
    J Cardiovasc Pharmacol; 2000 Sep; 36(3):329-37. PubMed ID: 10975590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of dual angiotensin converting enzyme/neutral endopeptidase inhibition, angiotensin converting enzyme inhibition, or AT1 antagonism on coronary microvasculature in spontaneously hypertensive rats.
    Pu Q; Larouche I; Schiffrin EL
    Am J Hypertens; 2003 Nov; 16(11 Pt 1):931-7. PubMed ID: 14573331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of long-term angiotensin II AT1 receptor blockade on survival, hemodynamics and cardiac remodeling in chronic heart failure in rats.
    Richer C; Fornes P; Cazaubon C; Domergue V; Nisato D; Giudicelli JF
    Cardiovasc Res; 1999 Jan; 41(1):100-8. PubMed ID: 10325957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Additive amelioration of left ventricular remodeling and molecular alterations by combined aldosterone and angiotensin receptor blockade after myocardial infarction.
    Fraccarollo D; Galuppo P; Schmidt I; Ertl G; Bauersachs J
    Cardiovasc Res; 2005 Jul; 67(1):97-105. PubMed ID: 15949473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AT1 receptor blockade limits myocardial injury and upregulates AT2 receptors during reperfused myocardial infarction.
    Jugdutt BI; Menon V
    Mol Cell Biochem; 2004 May; 260(1-2):111-8. PubMed ID: 15228092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrative control of coronary resistance vessel tone by endothelin and angiotensin II is altered in swine with a recent myocardial infarction.
    de Beer VJ; Sorop O; Pijnappels DA; Dekkers DH; Boomsma F; Lamers JM; Duncker DJ; Merkus D
    Am J Physiol Heart Circ Physiol; 2008 May; 294(5):H2069-77. PubMed ID: 18310517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AT1 receptor blockade increases cardiac bradykinin via neutral endopeptidase after induction of myocardial infarction in rats.
    Walther T; Siems WE; Hauke D; Spillmann F; Dendorfer A; Krause W; Schultheiss HP; Tschöpe C
    FASEB J; 2002 Aug; 16(10):1237-41. PubMed ID: 12153991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effects of combination therapy with angiotensin I-converting enzyme inhibitor and angiotensin 1 receptor antagonist on ventricular remodeling and expression of endothelial nitric oxide synthase].
    Zhang RY; Huang YL; Sun YH
    Zhonghua Yi Xue Za Zhi; 2005 Apr; 85(15):1053-6. PubMed ID: 16029550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin II AT1 receptor blockade improves renal perfusion in hypercholesterolemia.
    Chade AR; Rodriguez-Porcel M; Rippentrop SJ; Lerman A; Lerman LO
    Am J Hypertens; 2003 Feb; 16(2):111-5. PubMed ID: 12559676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coronary vasoconstrictor influence of angiotensin II is reduced in remodeled myocardium after myocardial infarction.
    Merkus D; Haitsma DB; Sorop O; Boomsma F; de Beer VJ; Lamers JM; Verdouw PD; Duncker DJ
    Am J Physiol Heart Circ Physiol; 2006 Nov; 291(5):H2082-9. PubMed ID: 16798821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of differential blockade of the renin-angiotensin system in postinfarcted rats.
    Lacour C; Roccon A; Galindo G; Canals F; Hogie M; Segondy D; Briand D; Roque C; Herbert JM; Nisato D
    Fundam Clin Pharmacol; 2004 Jun; 18(3):299-307. PubMed ID: 15147281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AT1 receptor blockade prevents cardiac dysfunction after myocardial infarction in rats.
    Berthonneche C; Sulpice T; Tanguy S; O'Connor S; Herbert JM; Janiak P; de Leiris J; Boucher F
    Cardiovasc Drugs Ther; 2005 Aug; 19(4):251-9. PubMed ID: 16193242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Interplay between the Renin Angiotensin System and Pacing Postconditioning Induced Cardiac Protection.
    Babiker F; Al-Jarallah A; Joseph S
    PLoS One; 2016; 11(11):e0165777. PubMed ID: 27814397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intramyocardial blood volume, perfusion and transit time in response to embolization of different sized microvessels.
    Möhlenkamp S; Beighley PE; Pfeifer EA; Behrenbeck TR; Sheedy PF; Ritman EL
    Cardiovasc Res; 2003 Mar; 57(3):843-52. PubMed ID: 12618246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin converting enzyme inhibition, AT1 receptor inhibition, and combination therapy with pacing induced heart failure: effects on left ventricular performance and regional blood flow patterns.
    Krombach RS; Clair MJ; Hendrick JW; Houck WV; Zellner JL; Kribbs SB; Whitebread S; Mukherjee R; de Gasparo M; Spinale FG
    Cardiovasc Res; 1998 Jun; 38(3):631-45. PubMed ID: 9747431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel angiotensin II AT(1) receptor antagonist irbesartan prevents thromboxane A(2)-induced vasoconstriction in canine coronary arteries and human platelet aggregation.
    Li P; Fukuhara M; Diz DI; Ferrario CM; Brosnihan KB
    J Pharmacol Exp Ther; 2000 Jan; 292(1):238-46. PubMed ID: 10604953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Experimental study of effect of carvedilol on myocardial collagen network remodeling after acute myocardial infarction in rats].
    Liu HB; Bian SY; Yang TS; Wang L; Yi J; Yang X
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2005 Sep; 17(9):537-40. PubMed ID: 16146598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.